ERC Consolidator Grant of 20 million NOK awarded to Johanna Olweus
Professor Johanna Olweus was awarded the Consolidator Grant from the European Research Council (ERC) for her project on immunotherapy “OUTSOURCE: Outsourcing cancer immunity to healthy donors”.
Olweus and colleagues will use the same mechanism that occurs when rejecting new organs during transplantation to “repel” cancer cells and treat cancer, a mechanism proposed by Olweus and colleagues in Science 2016
"Immunotherapy has revolutionized cancer treatment, but we still lack a curative treatment for the vast majority of patients who get cancer with the spread" says Johanna Olweus, professor at the Institute of Clinical Medicine and Oslo University Hospital.
ERC supports groundbreaking and innovative research through long-term funding. Consolidator Grant targets promising researchers in the phase 7-12 years after completing their doctorate. Olweus will receive NOK 20 million over five years for his project.
“The award is a huge recognition of the work that my research group is doing. Obtaining an ERC grant is a bit like getting a medal in a European Championship. It is a stamp of quality and shows that our research project is seen as pioneering, which is one of the main criteria for obtaining an ERC award. It is incredibly inspiring and motivating!”
Olweus has been leading the K.G.Jebsen Center for Immunotherapy for Cancer since 2013. The center is now in its final year of funding.
“The springboard I and the group have received through long-term research funding and support from the institutions where the research has been carried out, ie UiO and OUS, and through the Research Council, Health South-East, the Cancer Society and not least the K.G. Jebsen Foundation, have been absolutely crucial to get there we are today”, she says.
Read the full article (in Norwegian) here.